Jeena Sikho LifecareNSE:JSLL +1.52%87 Debt-to-Equity is 0.27 as of Mar. 2026, which is 13% above its 10-year median of 0.24. GuruFocus rates NSE:JSLL with a GF Score™ of 87/100 and a GF Value™ of ₹776.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 555 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks better than 60.9% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Jeena Sikho Lifecare's Debt-to-Equity or its related term are showing as below:
NSE:JSLL'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.24 Max: 1.95
Current: 0.27
During the past 8 years, the highest Debt-to-Equity Ratio of Jeena Sikho Lifecare was 1.95. The lowest was 0.00. And the median was 0.24.
NSE:JSLL's Debt-to-Equity is ranked better than 60.9% of 555
companies
in the Healthcare Providers & Services industry
Industry Median: 0.4
vs NSE:JSLL: 0.27
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Jeena Sikho Lifecare Debt-to-Equity Related Terms
Jeena Sikho Lifecare Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JSLL vs HCA, THC, DVA: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeena Sikho Lifecare (NSE:JSLL) has a Debt-to-Equity of 0.27 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Jeena Sikho Lifecare and its competitors. This is 13% above median its historical median of 0.24. According to the industry distribution chart, Jeena Sikho Lifecare ranks #217 out of 555 companies in the Healthcare Providers & Services industry, placing it in the top 39.1%.
Is Jeena Sikho Lifecare's Debt-to-Equity too high?
Jeena Sikho Lifecare's current Debt-to-Equity of 0.27 is 13% above median its 10-year median of 0.24. The Healthcare Providers & Services industry median Debt-to-Equity is 0.40. Jeena Sikho Lifecare's value of 0.27 is 32.5% below this industry median. Based on the distribution chart, Jeena Sikho Lifecare ranks #217 out of 555 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Jeena Sikho Lifecare has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #217 out of 555 companies for Debt-to-Equity. This puts Jeena Sikho Lifecare in the upper half of its industry. The industry median Debt-to-Equity is 0.40. Jeena Sikho Lifecare's value of 0.27 is 32.5% below this benchmark. While the company's 10-year median is 0.24 vs. the industry median of 0.40, Jeena Sikho Lifecare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.40, based on 555 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current Debt-to-Equity of 0.27 is 32.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current Debt-to-Equity is 0.27, which is 13% above median its own 10-year median of 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹776.38, compared to a current price of ₹570.40 — trading 26.5% below its estimated fair value. The current Debt-to-Equity is 0.27, which is 13% above median its 10-year median of 0.24 and 32.5% below the Healthcare Providers & Services industry median of 0.40. Jeena Sikho Lifecare's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Debt-to-Equity is 0.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹570.40 is trading 26.5% below its estimated GF Value™ of ₹776.38.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
Debt-to-Equity: 0.27 (13% above median its 10-year median of 0.24)
GF Value™: ₹776.38 vs. price of ₹570.40 (26.5% below fair value)
Industry Position: 32.5% below the Healthcare Providers & Services median (#217 of 555)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
87GF Score
Get the complete analysis for NSE:JSLL
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
